Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Pharma
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC
For now, approval in the PD-L1-positive population makes Trodelvy’s TNBC label broader than its rival. But AZ and Daiichi plan to catch up.
Angus Liu
Jun 24, 2026 5:00pm
Fierce Biotech
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO
Jun 24, 2026 3:03pm
Novartis’ ‘Relax Your Tight End’ wins Cannes Pharma Grand Prix
Jun 23, 2026 9:06am
Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials
Jun 9, 2026 11:20am
Gilead's Trodelvy stumbles in first-line NSCLC
Jun 9, 2026 11:14am
Gilead expanding access to Yescarta, Tecartus with Cencora deal
Jun 3, 2026 11:11am
